Alembic gets USFDA nod for Oseltamivir Phosphate for Oral Suspension
Oseltamivir Phosphate is an influenza neuraminidase inhibitor (NAI) indicated for treatment of acute, uncomplicated…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Zydus Lifesciences, Sunshine Healthcare sign JV to set up pharma facility in Sri Lanka
The facility, to be located at the Board of Investment zone in Horana, will be developed on nearly four acres of land, an an…
Indoco Remedies Goa Plant successfully clears Malta Medicines Authority audit
The facility has received EU GMP certification from the Malta Medicines Authority
Lupin gets tentative nod from US FDA for Enzalutamide tablets
The tentative approval covers the 40 mg, 80 mg, 120 mg, and 160 mg strengths
Shilpa Biologicals commissions ADC GMP manufacturing facility in Dharwad
The company informed that the facility which is fully operational, is designed to meet global regulatory approval standards
Lilly launches Tanstrive (Selpercatinib), a RET inhibitor to treat advanced cancers with RET gene…
Available in India in 40 mg, 80 mg, 120 mg and 160 mg tablet strengths; administered orally twice daily
Concord Biotech clears Kenya, Uganda regulatory inspection
The inspection was conducted from June 18 to June 24, 2026
Pharma deal value rises 156.8% in May 2026: GlobalData
Healthcare sector records 68 deals worth $18.5 billion, while venture capital funding declines 21.5 per cent year-on-year
Indoco Remedies clears Malta Medicines Authority audit
The facility has received EU GMP certification from the Malta Medicines Authority confirming that it complies with the Good…
Zydus to acquire Assertio in all-cash tender offer
Assertio is focused on specialty and oncology supportive-care therapies
Lupin gets US FDA nod for Famotidine Injection, USP
This product would be manufactured at Lupin’s Nagpur facility in India
Healthcare deal value rises 340 per cent in April 2026: GlobalData
Sun Pharma-Organon, Eli Lilly-Kelonia and Gilead-Tubulis among the major deals reported during the month
Alembic Pharma gets USFDA nod for Methotrexate Injection USP, 50 mg/2 mL multi-dose vials and 1g/40…
Methotrexate Injection is a folate analog metabolic inhibitor indicated for neoplastic diseases
Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical…
The shift reflects intensifying demand for metabolic therapies and growing logistics risk, signaling a structural move toward…
The GLP-1 revolution
A new class of drugs is reshaping global health,but India’s generics wave could change who benefits. Dr Rajpushpa Labh,Consultant…
Lupin completes acquisition of VISUfarma
The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to over 60 branded products spanning dry eye, glaucoma,…
Glenmark to manage end-to-end commercialisation and distribution for RYALTRIS in US
RYALTRIS is Glenmark’s first innovative product introduced into the US market
Biopharma gets a boost in Budget 2026 with ₹10,000-crore outlay
Biopharma Shakti programme to boost domestic manufacturing of biologics and biosimilars. The Budget also announces customs duty…
Odisha’s pharma pitch
The recently held Odisha Pharma Summit 2025, the state’s first dedicated summit focused on pharmaceuticals, medical devices, and…
Natco to launch generic of Risdiplam for SMA patients
The company said it will launch the product immediately, with MRP of ₹15,900